Efficacy dilution in randomized placebo-controlled vaginal microbicide trials - Wikidata - awgldk - TriplyDB

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

http://www.wikidata.org/entity/Q30491264

about

Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.Shape of vaginal suppositories affects willingness-to-try and preference Effect of computer-assisted interviewing on self-reported sexual behavior data in a microbicide clinical trial How common and frequent is heterosexual anal intercourse among South Africans? A systematic review and meta-analysis.Notes on the frequency of routinely collected and self-reported behavioral data in HIV prevention trials.Increasing the effectiveness of vaginal microbicides: a biophysical framework to rethink behavioral acceptability Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa An acceptability and safety study of the Duet cervical barrier and gel delivery system in Zimbabwe Microbicide clinical trial adherence: insights for introduction Effect of a facility-based multifaceted intervention on the quality of obstetrical care: a cluster randomized controlled trial in Mali and Senegal.Rectal microbicide development.Rethinking prevention of HIV type 1 infection.Anal sex, vaginal practices, and HIV incidence in female sex workers in urban Kenya: implications for the development of intravaginal HIV prevention methods.Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance "Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention Condoms, Lubricants and Rectal Cleansing: Practices Associated with Heterosexual Penile-Anal Intercourse Amongst Participants in an HIV Prevention Trial in South Africa, Uganda and Zimbabwe Feasibility, performance, and acceptability of the Wisebag™ for potential monitoring of daily gel applicator use in Durban, South Africa.Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial.Who will Benefit from a Wide-Scale Introduction of Vaginal Microbicides in Developing Countries?Heterosexual anal intercourse: a neglected risk factor for HIV?Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition.Prevalence and Frequency of Heterosexual Anal Intercourse Among Young People: A Systematic Review and Meta-analysis.Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?Lost in Translation: Language, Terminology, and Understanding of Penile-Anal Intercourse in an HIV Prevention Trial in South Africa, Uganda, and Zimbabwe.Prolonged expression of an anti-HIV-1 gp120 minibody to the female rhesus macaque lower genital tract by AAV gene transfer HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa.Sharing of Investigational Drug Among Participants in the Voice Trial.Preference between precoital and daily use of Duet® and BufferGel in Zimbabwe.An adaptive design to bridge the gap between Phase 2b/3 microbicide effectiveness trials and evidence required for licensure.Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel.A novel breath test to directly measure use of vaginal gel and condoms.Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques.The Role of Mathematical Models in Vaccine Development and Public Health Decision Making

P2860

Q21203732-2878B302-F489-4CEC-8937-FD6E8057EB80 Q30499386-9AADC9B1-2EEA-48D2-BA73-E5C3CAD5D1C7 Q30538073-E4AC9843-AB92-405C-A3CF-C9D8A2EE89E3 Q30572895-D99BB276-E781-4AEF-B611-09D5BB9A8AEF Q30854994-FD830BE4-5F67-4733-A8E1-878A667BDF18 Q33722251-D5CCF80E-198B-4B35-9B84-BB6EFB416EE2 Q33761194-ADABBB42-775D-4DCF-A92B-49FFEDA91FE2 Q33971596-44F79D55-B480-49C1-B338-1F98A57B72DE Q34075021-A13B1B85-51D5-4557-B62F-62DBF239486E Q34337475-55538867-D9E9-4026-B035-B690FB91BE58 Q34564067-A1615514-C172-4505-B7FD-6105101E2F97 Q34575590-2AD6B6AA-93EA-49A4-A8C7-A7E40E2FE95C Q34767070-5AB779D8-D9E7-45BA-8380-971E941D5FCD Q35267695-FC858563-CD9F-4D14-8EBC-B38F33D66092 Q35619584-C5AFF922-D1D1-4454-A579-6B834B1D8CA6 Q35736962-B494B9DF-D6FF-48BE-B794-786325525266 Q35903632-247583AE-B5D1-4C87-BAFA-B4CFFCE47F5A Q36421474-8202C5A4-C85C-43D8-8E0D-4673CC37D063 Q36581869-B08B2C82-6462-48D6-A48C-CC572D929597 Q36763200-8F4DC31E-8E89-44EB-9E41-EA2342B56CE0 Q36906506-BB0002E9-044D-4EB2-AFA9-1AA4BC87E318 Q37265920-14D95C55-E461-4FD2-8662-2986C46CFC31 Q37348456-16686267-0CDD-4B1A-A507-9F24F6B4789D Q37527837-7AC699CA-2CD9-4308-BFF9-C39ADFF80BA1 Q37610612-BF2DC81B-DB68-4136-8278-BBCC0B99F4A2 Q37777192-27FCA3D9-407B-421F-B8EE-4F158F38C5C4 Q38331052-414F0186-ED7B-4C6E-BE9D-20B0C0B2D8F2 Q38852654-90F23A43-80CD-4767-BBC1-83AC047BA787 Q38856909-75A8C852-5D60-4027-A68B-F30E4502E6FC Q38981274-57BBA49B-F24C-4828-A4DC-E97F8972F9B8 Q39047461-B1510BB4-E614-4B57-A4B5-24D58E9B7ECE Q39265007-21EC976C-ACE3-4EFC-A338-0FB48D3EACF3 Q40047967-A99DBF27-64EA-4F49-9F79-2B7B413E4713 Q44016003-F6B37995-AD1D-4A53-A174-D8CD093532D7 Q45114335-2C664309-61CC-4EA7-83FB-4DAD9F4974D9 Q46361978-12DE9A64-2B15-423D-90CB-69BE7820CEA2 Q55005002-BC7FAD9C-80AA-4615-AD22-C963A2969875 Q57097843-5F563412-5195-441D-A835-D69A3B4D5A02

P2860

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

http://www.wikidata.org/entity/Q30491264

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

@ast

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

@en

type

label

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

@ast

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

@en

prefLabel

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

@ast

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

@en

P1433

Q30491264-D833DF50-8FC4-48DA-A005-E1AC75BB0778

P1476

Q30491264-C0D273BC-5A70-47E9-9C77-12C5AE8386E3

P2093

Q30491264-31EE43DC-F162-4860-9458-9D956A8316BD

Q30491264-C43DE549-9105-4BF3-8ADF-21BDF99FB85E

Q30491264-F89582C7-F79E-4247-A32E-A6166ADEE584

P2860

Q30491264-00A1703E-329C-4F3B-B912-9C354228713A

Q30491264-24FFE46B-17B8-4A8F-A1B0-A5970E2D14E7

Q30491264-299FA0E6-260D-49E6-9693-654DB1EC80EA

Q30491264-3C4EE11A-ACD0-4A06-91AE-3EFA23375E0A

Q30491264-57567BB1-C2C4-407A-B0B2-D0F6CC030B8B

Q30491264-759E5372-45D8-4EBD-A3D2-0522192DA4D8

Q30491264-83D4FB15-1FE2-4039-A6DA-AC810B182973

Q30491264-87E11215-D42E-4690-B11A-228756F65DF0

Q30491264-8AB89FC1-B00B-45E5-87A5-B360053CA04A

Q30491264-BBFC66C7-5D5E-4D50-9F3A-4A5DBECD39B8

P2888

Q30491264-047A8F1B-C75B-4913-BF66-26E80CAA5934

P304

Q30491264-259F2436-14E5-420D-9B37-2542A88AEE73

P31

Q30491264-F8C3B181-5D42-487C-A206-2C8F057D1692

P356

Q30491264-F156523C-EB19-4EFB-8465-D4E9F64940F2

P478

Q30491264-2C7A8A84-6FC2-465E-9BB6-6C1710D3E31A

P50

Q30491264-20BCD236-54B0-4F72-909A-685F47CD4C91

P577

Q30491264-178AD40C-2D79-4A39-ABF3-D134C04B1FA8

P5875

Q30491264-7CCC9550-56A4-4CEC-9133-B012F69AD701

P6179

Q30491264-2E087721-27D9-459E-AEE3-C6FC4F146B3D

P698

Q30491264-495531D2-F4D9-40C3-B039-46EC234AAAD5

P921

Q30491264-84673CC5-45EF-4BAB-848B-2C3133C70BE7

P932

Q30491264-D62F0A8D-F4C3-4C15-8FB8-224FAFBBFFB8

P356

P1433

Emerging Themes in Epidemiology

P1476

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

@en

P2093

Benoît R Mâsse

http://www.w3.org/2001/XMLSchema#string

Kamal Desai

http://www.w3.org/2001/XMLSchema#string

Marie-Claude Boily

http://www.w3.org/2001/XMLSchema#string

P2860

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria

SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.

Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria.

Persisting with prevention: the importance of adherence for HIV prevention

Vaginal microbicides and the prevention of HIV transmission

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.

The epidemiological and control implications of HIV transmission probabilities within partnerships.

Heterosexual anal intercourse increases risk of HIV infection among young South African men.

P2888

P304

5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-7622-6-5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Dobromir Dimitrov

P577

2009-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26883912

http://www.w3.org/2001/XMLSchema#string

P6179

1026620889

http://www.w3.org/2001/XMLSchema#string

P698

19818138

http://www.w3.org/2001/XMLSchema#string

P921

P932

2768687

http://www.w3.org/2001/XMLSchema#string